Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Recent studies have implicated fatty acid-dependent activation of the serine kinase IKKβ, which plays a key role in tissue inflammation, in the pathogenesis of insulin resistance. High doses of salicylates have recently been shown to inhibit IKKβ activity and might therefore ameliorate insulin resistance and improve glucose tolerance in patients with type 2 diabetes. To test this hypothesis, we studied nine type 2 diabetic subjects before and after 2 weeks of treatment with aspirin (∼7 g/d). Subjects underwent mixed-meal tolerance tests and hyperinsulinemic-euglycemic clamps with [6,6-2H2]glucose to assess glucose turnover before and after treatment. High-dose aspirin treatment resulted in a ∼25% reduction in fasting plasma glucose, associated with a ∼15% reduction in total cholesterol and C-reactive protein, a ∼50% reduction in triglycerides, and a ∼30% reduction in insulin clearance, despite no change in body weight. During a mixed-meal tolerance test, the areas under the curve for plasma glucose and fatty acid levels decreased by ∼20% and ∼50%, respectively. Aspirin treatment also resulted in a ∼20% reduction in basal rates of hepatic glucose production and a ∼20% improvement in insulin-stimulated peripheral glucose uptake under matched plasma insulin concentrations during the clamp. In conclusion, these data support the hypothesis that IKKβ represents a new target for treating type 2 diabetes mellitus.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, inhibition or inactivation of JNK (18,26) or IKK (22,24,25,27) improves insulin sensitivity in various models of insulin resistance in association with reduced inhibitory serine phosphorylation of IRS-1 (18).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [27]
In the citing paper
“Accordingly, KO or inhibition of JNK1 or IKKβ prevents insulin resistance in cell and mouse models (18,22,24,25,87) as well as human models (27) of insulin resistance.”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [27]
In the citing paper
“Moreover, the insulin resistance was ameliorated with salicylates, which also protected against insulin resistance in rodents after acute lipid infusion,127 and reversed insulin resistance in people with type 2 diabetes mellitus.128”
From Lipid-induced insulin resistance: unravelling the mechanism (2010) · cites this paper as [128]
Citations
Cites
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Cellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714
Self-citationYuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.-W., Karin, M., & Shoelson, S. E. (2001) · Science · doi:10.1126/science.1061620 · Cited by 1,884
Self-citationRole of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728
The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β
Yin, M.-J., Yamamoto, Y., & Gaynor, R. B. (1998) · Nature · doi:10.1038/23948 · Cited by 1,590
Mechanism of free fatty acid-induced insulin resistance in humans.
Roden, M., Price, T. B., Perseghin, G., Petersen, K. F., Rothman, D. L., Cline, G. W., & Shulman, G. I. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118742 · Cited by 1,539
Self-citationDresner, A., Laurent, D., Marcucci, M., Griffin, M. E., Dufour, S., Cline, G. W., Slezak, L. A., Andersen, D. K., Hundal, R. S., Rothman, D. L., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5001 · Cited by 1,311
Self-citationGriffin, M. E., Marcucci, M. J., Cline, G. W., Bell, K., Barucci, N., Lee, D., Goodyear, L. J., Kraegen, E. W., White, M. F., & Shulman, G. I. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1270 · Cited by 1,267
Self-citationShulman, G. I., Rothman, D. L., Jue, T., Stein, P., DeFronzo, R. A., & Shulman, R. G. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001253220403 · Cited by 1,248
Self-citationMechanism by which metformin reduces glucose production in type 2 diabetes.
Hundal, R. S., Krssak, M., Dufour, S., Laurent, D., Lebon, V, Chandramouli, V, Inzucchi, S. E., Schumann, W. C., Petersen, K. F., Landau, B. R., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2063 · Cited by 1,052
Self-citation
Research works printed but not linked: 3
- Ebstein, 1877, Berliner Klinische Wochenschrift, 24, 337
- Giugliano, 1982, Diabete Metab, 8, 279
- Shulman, 1990, Am J Physiol, 259, E335
Cited by
Items 101–200 of 554
Matsumoto, M., Ogawa, W., Akimoto, K., Inoue, H., Miyake, K., Furukawa, K., Hayashi, Y., Iguchi, H., Matsuki, Y., Hiramatsu, R., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18816 · Cited by 178
Metabolic impact of estrogen signalling through ERalpha and ERbeta
Foryst-Ludwig, A., & Kintscher, U. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.06.012 · Cited by 178
From fatty liver to fibrosis: A tale of “second hit”
Basaranoglu, M. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i8.1158 · Cited by 176
Salicylate-Based Anti-Inflammatory Drugs Inhibit the Early Lesion of Diabetic Retinopathy
Zheng, L., Howell, S. J., Hatala, D. A., Huang, K., & Kern, T. S. (2007) · Diabetes · doi:10.2337/db06-0789 · Cited by 176
Pharmacological effects of berberine and its derivatives: a patent update
Jin, Y., Khadka, D. B., & Cho, W.-J. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2016.1118060 · Cited by 174
The insulin resistance syndrome: physiological considerations
Kashyap, S. R., & Defronzo, R. A. (2007) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2007.001 · Cited by 172
Obesity-Related Upregulation of Monocyte Chemotactic Factors in Adipocytes
Jiao, P., Chen, Q., Shah, S., Du, J., Tao, B., Tzameli, I., Yan, W., & Xu, H. (2009) · Diabetes · doi:10.2337/db07-1344 · Cited by 166
Tang, X., Guilherme, A., Chakladar, A., Powelka, A. M., Konda, S., Virbasius, J. V., Nicoloro, S. M. C., Straubhaar, J., & Czech, M. P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507660103 · Cited by 164
Adipocyte differentiation induces dynamic changes in NF-κB expression and activity
Berg, A. H., Lin, Y., Lisanti, M. P., & Scherer, P. E. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00002.2004 · Cited by 162
Turning back time with emerging rejuvenation strategies
Mahmoudi, S., Xu, L., & Brunet, A. (2019) · Nature Cell Biology · doi:10.1038/s41556-018-0206-0 · Cited by 161
Hypothalamic inflammation: a double‐edged sword to nutritional diseases
Cai, D., & Liu, T. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06388.x · Cited by 159
Bradley, R. L., Fisher, F. M., & Maratos‐Flier, E. (2008) · Obesity · doi:10.1038/oby.2008.39 · Cited by 160
Inflammation and adipose tissue macrophages in lipodystrophic mice
Herrero, L., Shapiro, H., Nayer, A., Lee, J., & Shoelson, S. E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905310107 · Cited by 160
Self-citationDiabetes and inflammation: Fundamental aspects and clinical implications
Garcia, C., Feve, B., Ferré, P., Halimi, S., Baizri, H., Bordier, L., Guiu, G., Dupuy, O., Bauduceau, B., & Mayaudon, H. (2010) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.07.001 · Cited by 159
Ford, R. J., Fullerton, M. D., Pinkosky, S. L., Day, E. A., Scott, J. W., Oakhill, J. S., Bujak, A. L., Smith, B. K., Crane, J. D., Blümer, R. M., et al. (2015) · Biochemical Journal · doi:10.1042/bj20150125 · Cited by 157
Lee, J. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0023-8 · Cited by 158
Šoškić, S., Dobutović, B. D., Sudar-Milovanovic, E. M., Obradovic, M. M., Nikolić, D., Djordjevic, J. D., Radak, D. J., Mikhailidis, D. P., & Isenović, E. R. (2011) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401105010153 · Cited by 171
Insulin Resistance and Its Contribution to Colon Carcinogenesis
Komninou, D., Ayonote, A., Richie, J. P., & Rigas, B. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322800410 · Cited by 156
Interleukin-1 Receptor Antagonist: A New Therapy for Type 2 Diabetes Mellitus
Akash, M. S. H., Shen, Q., Rehman, K., & Chen, S. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23057 · Cited by 170
Shulman, G. I. (2004) · Physiology · doi:10.1152/physiol.00007.2004 · Cited by 149
Self-citationHigh protein intake reduces intrahepatocellular lipid deposition in humans
Bortolotti, M., Kreis, R., Debard, C., Cariou, B., Faeh, D., Chetiveaux, M., Ith, M., Vermathen, P., Stefanoni, N., Lê, K.-A., et al. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.27296 · Cited by 146
Sriwijitkamol, A., Christ-Roberts, C., Berria, R., Eagan, P., Pratipanawatr, T., DeFronzo, R. A., Mandarino, L. J., & Musi, N. (2006) · Diabetes · doi:10.2337/diabetes.55.03.06.db05-0677 · Cited by 145
Innate immune activation in obesity
Lumeng, C. N. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.10.002 · Cited by 142
Oliveira, A. G., Carvalho, B. M., Tobar, N., Ropelle, E. R., Pauli, J. R., Bagarolli, R. A., Guadagnini, D., Carvalheira, J. B. C., & Saad, M. J. A. (2011) · Diabetes · doi:10.2337/db09-1907 · Cited by 137
RetractedGetting the message across: mechanisms of physiological cross talk by adipose tissue
Lee, D.-E., Kehlenbrink, S., Lee, H., Hawkins, M., & Yudkin, J. S. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00015.2009 · Cited by 137
Hyporesponsiveness to the anti-inflammatory action of interleukin-10 in type 2 diabetes
Barry, J. C., Shakibakho, S., Durrer, C., Simtchouk, S., Jawanda, K. K., Cheung, S. T., Mui, A. L., & Little, J. P. (2016) · Scientific Reports · doi:10.1038/srep21244 · Cited by 131
Molecular mechanisms of lipid‐induced insulin resistance in muscle, liver and vasculature
Krebs, M., & Roden, M. (2005) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00439.x · Cited by 129
Goldfine, A. B., Conlin, P. R., Halperin, F., Koska, J., Permana, P., Schwenke, D., Shoelson, S. E., & Reaven, P. D. (2013) · Diabetologia · doi:10.1007/s00125-012-2819-3 · Cited by 129
Self-citationEngebretson, S. P., & Kocher, T. (2013) · Journal of Periodontology · doi:10.1902/jop.2013.1340017 · Cited by 156
Radin, M. S., Sinha, S., Bhatt, B. A., Dedousis, N. L., & O'Doherty, R. M. (2007) · Diabetologia · doi:10.1007/s00125-007-0861-3 · Cited by 133
Koška, J., Ortega, E., Bunt, J. C., Gasser, A., Impson, J., Hanson, R. L., Forbes, J. M., de Courten, B. V., & Krakoff, J. A. (2008) · Diabetologia · doi:10.1007/s00125-008-1239-x · Cited by 122
Cardiovascular risk associated with the metabolic syndrome
Lindsay, R. S., & Howard, B. V. (2004) · Current Diabetes Reports · doi:10.1007/s11892-004-0013-9 · Cited by 139
Therapeutic Approaches to Target Inflammation in Type 2 Diabetes
Goldfine, A. B., Fonseca, V., & Shoelson, S. E. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.148833 · Cited by 116
Self-citationNF-κB and the regulation of hematopoiesis
Bottero, V., Withoff, S., & Verma, I. M. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401888 · Cited by 142
Goutal, C. M., Brugmann, B. L., & Ryan, K. A. (2012) · Journal of the American Animal Hospital Association · doi:10.5326/jaaha-ms-5745 · Cited by 122
Eicosanoids, β-cell function, and diabetes
Luo, P., & Wang, M.-H. (2011) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2011.06.001 · Cited by 131
Zick, Y. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320812 · Cited by 130
Role and function of macrophages in the metabolic syndrome
Bhargava, P., & Lee, C. (2012) · Biochemical Journal · doi:10.1042/bj20111708 · Cited by 130
Inflammatory Mediators in Gestational Diabetes Mellitus
Richardson, A. C., & Carpenter, M. W. (2007) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2007.04.001 · Cited by 129
Kumar, A., Negi, G., & Sharma, S. S. (2012) · Biochimie · doi:10.1016/j.biochi.2012.01.023 · Cited by 116
Stark, R., Guebre‐Egziabher, F., Zhao, X., Feriod, C. N., Dong, J., Alves, T. C., Ioja, S., Pongratz, R. L., Bhanot, S., Roden, M., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.c113.544759 · Cited by 115
Self-citationMauer, J., Chaurasia, B., Plum, L., Quast, T., Hampel, B., Blüher, M., Kolanus, W., Kahn, C. R., & Brüning, J. C. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000938 · Cited by 117
Lasram, M. M., Dhouib, I. B., Annabi, A. B., Fazâa, S. E., & Gharbi, N. (2014) · Toxicology · doi:10.1016/j.tox.2014.04.009 · Cited by 111
RNAi-based therapeutic strategies for metabolic disease
Czech, M., Aouadi, M., & Tesz, G. J. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.57 · Cited by 118
Berberine Inhibits Inflammatory Response and Ameliorates Insulin Resistance in Hepatocytes
Lou, T., Zhang, Z., Xi, Z., Liu, K., Li, L., Liu, B., & Huang, F. (2010) · Inflammation · doi:10.1007/s10753-010-9276-2 · Cited by 112
Austin, R. L., Rune, A., Bouzakri, K., Zierath, J. R., & Krook, A. (2008) · Diabetes · doi:10.2337/db07-0763 · Cited by 105
IL6 genotypes and colon and rectal cancer
Slattery, M. L., Wolff, R. K., Herrick, J. S., Caan, B. J., & Potter, J. D. (2007) · Cancer Causes & Control · doi:10.1007/s10552-007-9049-x · Cited by 103
Metabolic Inflammation-Differential Modulation by Dietary Constituents
Lyons, C., Kennedy, E., & Roche, H. (2016) · Nutrients · doi:10.3390/nu8050247 · Cited by 104
Kang, W., Hong, H. J., Guan, J., Kim, D. G., Yang, E.-J., Koh, G., Park, D.-B., Han, C. H., Lee, Y. J., & Lee, D.-H. (2011) · Metabolism · doi:10.1016/j.metabol.2011.08.003 · Cited by 104
Lappas, M., Yee, K., Permezel, M., & Rice, G. E. (2004) · Endocrinology · doi:10.1210/en.2004-0809 · Cited by 102
Insulin Resistance in the Defense against Obesity
Saltiel, A. R. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.03.001 · Cited by 116
Anti-Inflammatory Strategies Targeting Metaflammation in Type 2 Diabetes
Kuryłowicz, A., & Koźniewski, K. (2020) · Molecules · doi:10.3390/molecules25092224 · Cited by 99
Martin, S., Cule, M., Basty, N., Tyrrell, J., Beaumont, R. N., Wood, A. R., Frayling, T. M., Sorokin, E. P., Whitcher, B. J., Liu, Y., et al. (2021) · Diabetes · doi:10.2337/db21-0129 · Cited by 115
Suppressing adipocyte inflammation promotes insulin resistance in mice
Zhu, Q., An, Y. A., Kim, M., Zhang, Z., Zhao, S., Zhu, Y., Asterholm, I. W., Kusminski, C. M., & Scherer, P. E. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101010 · Cited by 99
Stressed out about obesity and insulin resistance
de Luca, C., & Olefsky, J. M. (2006) · Nature Medicine · doi:10.1038/nm0106-41 · Cited by 112
Xiang, A. H., Kawakubo, M., Trigo, E., Kjos, S. L., & Buchanan, T. A. (2009) · Diabetes Care · doi:10.2337/dc09-1493 · Cited by 104
Effect of Etanercept on Insulin Sensitivity in Nine Patients with Psoriasis
Marra, M., Campanati, A., Testa, R., Sirolla, C., Bonfigli, A. R., Franceschi, C., Marchegiani, F., & Offidani, A. (2007) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200702000408 · Cited by 97
Liu, D., Zhang, S., Li, S., Zhang, Q., Cai, Y., Li, P., Li, H., Shen, B., Liao, Q., Hong, Y., et al. (2023) · BMC Biology · doi:10.1186/s12915-023-01578-2 · Cited by 105
Mechanistic and Pharmacological Issues of Aspirin as an Anticancer Agent
Dovizio, M., Tacconelli, S., Sostres, C., Ricciotti, E., & Patrignani, P. (2012) · Pharmaceuticals · doi:10.3390/ph5121346 · Cited by 105
Dong, X., Zhao, S.-X., Yin, X., Wang, H., Wei, Z.-G., & Zhang, Y. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.10.111 · Cited by 97
McCarty, M. F., & Block, K. I. (2006) · Integrative Cancer Therapies · doi:10.1177/1534735406291499 · Cited by 96
Elevated C-Reactive Protein Levels in the Development of Type 1 Diabetes
Chase, H. P., Cooper, S., Osberg, I., Stene, L. C., Barriga, K., Norris, J., Eisenbarth, G. S., & Rewers, M. (2004) · Diabetes · doi:10.2337/diabetes.53.10.2569 · Cited by 95
Hermes, G. L., Rosenthal, L., Montag, A., & McClintock, M. K. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00368.2005 · Cited by 94
Free Fatty Acids Repress the GLUT4 Gene Expression in Cardiac Muscle via Novel Response Elements
Armoni, M., Harel, C., Bar‐Yoseph, F., Milo, S., & Karnieli, E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502740200 · Cited by 102
Pietropaolo, M., Barinas-Mitchell, E., & Kuller, L. H. (2007) · Diabetes · doi:10.2337/db06-0880 · Cited by 94
The Role of Mitochondria in Diabetic Kidney Disease
Hallan, S. I., & Sharma, K. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0748-0 · Cited by 98
Treatment of insulin resistance in diabetes mellitus
Lebovitz, H. E., & Banerji, M. A. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.051 · Cited by 102
Yaribeygi, H., Maleki, M., Sathyapalan, T., Jamialahmadi, T., & Sahebkar, A. (2021) · Journal of Diabetes Research · doi:10.1155/2021/7796727 · Cited by 91
Modulation of immune function in the bovine uterus peripartum
Pascottini, O. B., & LeBlanc, S. J. (2020) · Theriogenology · doi:10.1016/j.theriogenology.2020.01.042 · Cited by 98
Tantiwong, P., Shanmugasundaram, K., Monroy, A., Ghosh, S., Li, M., DeFronzo, R. A., Cersósimo, E., Sriwijitkamol, A., Mohan, S., & Musi, N. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00776.2009 · Cited by 96
O’Brien, A. J., Villani, L. A., Broadfield, L. A., Houde, V. P., Galic, S., Blandino, G., Kemp, B. E., Tsakiridis, T., Muti, P., & Steinberg, G. R. (2015) · Biochemical Journal · doi:10.1042/bj20150122 · Cited by 90
MicroRNAs in Tumor Cell Metabolism: Roles and Therapeutic Opportunities
Pedroza‐Torres, A., Romero-Cordoba, S. L., Justo-Garrido, M., Salido-Guadarrama, I., Rodríguez‐Bautista, R., Montaño, S., Muñiz-Mendoza, R., Arriaga-Canon, C., Fragoso‐Ontiveros, V., Álvarez-Gómez, R. M., et al. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01404 · Cited by 97
Metabolic Health, Insulin, and Breast Cancer: Why Oncologists Should Care About Insulin
Yee, L. D., Mortimer, J. E., Natarajan, R. D., Dietze, E. C., & Seewaldt, V. L. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00058 · Cited by 113
A round trip from nonalcoholic fatty liver disease to diabetes: molecular targets to the rescue?
Lonardo, A., Lugari, S., Ballestri, S., Nascimbeni, F., Baldelli, E., & Maurantonio, M. (2019) · Acta Diabetologica · doi:10.1007/s00592-018-1266-0 · Cited by 88
Petersen, K. F., & Shulman, G. I. (2006) · Obesity · doi:10.1038/oby.2006.280 · Cited by 87
Self-citationMatsuzaka, T., & Shimano, H. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2011.00111.x · Cited by 104
Ageing and metabolism: drug discovery opportunities
Curtis, R., Geesaman, B. J., & DiStefano, P. S. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1777 · Cited by 98
Inflammation and Insulin Resistance
Bloomgarden, Z. T. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1619 · Cited by 88
Aspirin, NSAIDs, and Colorectal Cancer: Possible Involvement in an Insulin-Related Pathway
Slattery, M. L., Samowitz, W. S., Hoffman, M. D., Ne, K., Levin, T. R., & Neuhausen, S. L. (2004) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.538.13.4 · Cited by 91
miRNA-Based Technologies in Cancer Therapy
Pagoni, M. N., Cava, C., Sideris, D. C., Avgeris, M., Zoumpourlis, V., Michalopoulos, I., & Drakoulis, N. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13111586 · Cited by 100
AMPK: mediating the metabolic effects of salicylate-based drugs?
Steinberg, G. R., Dandapani, M., & Hardie, D. G. (2013) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.06.002 · Cited by 83
Patsouris, D., Neels, J. G., Fan, W., Li, P.-P., Nguyen, M. T. A., & Olefsky, J. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.041665 · Cited by 84
Mitochondrial dysfunction and type 2 diabetes
Parish, R., & Petersen, K. F. (2005) · Current Diabetes Reports · doi:10.1007/s11892-005-0006-3 · Cited by 96
Self-citationSmith, B. K., Ford, R. J., Desjardins, E. M., Green, A. E., Hughes, M. C., Houde, V. P., Day, E. A., Marcinko, K., Crane, J. D., Mottillo, E. P., et al. (2016) · Diabetes · doi:10.2337/db16-0564 · Cited by 79
Wan, Q.-L., Zheng, S., Wu, G.-S., & Luo, H. (2013) · Experimental Gerontology · doi:10.1016/j.exger.2013.02.020 · Cited by 87
Green, C. J., Macrae, K., Fogarty, S., Hardie, D. G., Sakamoto, K., & Hundal, H. S. (2011) · Biochemical Journal · doi:10.1042/bj20101517 · Cited by 78
Adipose tissues as endocrine target organs
Lanthier, N., & Leclercq, I. A. (2014) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2014.07.002 · Cited by 96
Genetic determinants and molecular pathways in the pathogenesis of Type 2 diabetes
Jin, W., & Patti, M.-E. (2009) · Clinical Science · doi:10.1042/cs20080090 · Cited by 78
Kim, J., Yeh, D. C., Ver, M. R., Li, Y., Carranza, A., Conrads, T. P., Veenstra, T. D., Harrington, M. A., & Quon, M. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501439200 · Cited by 88
Sorafenib synergizes with metformin in NSCLC through AMPK pathway activation
Groenendijk, F. H., Mellema, W. W., van der Burg, E., Schut, E., Hauptmann, M., Horlings, H. M., Willems, S. M., van den Heuvel, M. M., Jonkers, J., Smit, E. F., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29113 · Cited by 76
Evolutionary origins of insulin resistance: a behavioral switch hypothesis
Watve, M. G., & Yajnik, C. S. (2007) · BMC Evolutionary Biology · doi:10.1186/1471-2148-7-61 · Cited by 114
Drug-Induced Glucose Alterations Part 1: Drug-Induced Hypoglycemia
Vue, M. H., & Setter, S. M. (2011) · Diabetes Spectrum · doi:10.2337/diaspect.24.3.171 · Cited by 85
Raetzsch, C. F., Brooks, N. L., Alderman, J. M., Moore, K. S., Hosick, P. A., Klebanov, S., Akira, S., Bear, J. E., Baldwin, A. S., Mackman, N., et al. (2009) · Hepatology · doi:10.1002/hep.22999 · Cited by 77
Aggravation by prostaglandin E2 of interleukin-6-dependent insulin resistance in hepatocytes #
Henkel, J., Neuschäfer-Rube, F., Pathe-Neuschäfer-Rube, A., & Püschel, G. P. (2009) · Hepatology · doi:10.1002/hep.23064 · Cited by 73
Mori, M. A., Liu, M., Bézy, O., Almind, K., Shapiro, H., Kasif, S., & Kahn, C. R. (2010) · Diabetes · doi:10.2337/db10-0367 · Cited by 76
Is liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis
Loria, P., Lonardo, A., & Targher, G. (2008) · Clinical Science · doi:10.1042/cs20070311 · Cited by 72
Leptin receptor modulation of adiposity and fertility
Israel, D. D., & Chua, S. C. (2009) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2009.07.004 · Cited by 82
Adiponectin and C-reactive protein in obesity, type 2 diabetes, and monodrug therapy
Putz, D., Goldner, W. S., Bar, R. S., Haynes, W. G., & Sivitz, W. I. (2004) · Metabolism · doi:10.1016/j.metabol.2004.06.013 · Cited by 76
Manoel-Caetano, F. S., Xavier, D. J., Evangelista, A. F., Takahashi, P., Collares, C. V. A., Puthier, D., Foss‐Freitas, M. C., Foss, M. C., Donadi, E. A., Passos, G. A. S., et al. (2012) · Gene · doi:10.1016/j.gene.2012.09.090 · Cited by 72
Type 2 diabetes mellitus as inflammatory disease
Zozulińska‐Ziółkiewicz, D., & Wierusz‐Wysocka, B. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.06.007 · Cited by 83
Metadata
- Authors
- Hundal, R. S., Petersen, K. F., Mayerson, A. B., Randhawa, P. S., Inzucchi, S., Shoelson, S. E., & Shulman, G. I.
- Affiliations
- Yale University (US)
- Joslin Diabetes Center (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Shulman, Gerald I.
- Venue
- Journal of Clinical Investigation
- Published
- 2002-05-15
- Volume
- 109
- Issue
- 10
- Pages
- 1321-1326
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W4246592598
- Cited by
- 557
- References
- 24
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 21 · 2023: 17 · 2022: 12 · 2021: 11 · 2020: 19 · 2019: 12 · 2018: 21 · 2017: 17 · 2016: 24 · 2015: 32 · 2014: 33 · 2013: 24 · 2012: 24
- FWCI
- 16.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Funders
- Yale University
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- high-dose aspirin, salicylates, type 2 diabetes, glucose metabolism, insulin resistance, IKKβ, serine kinase, fatty acid signaling, glucose turnover, hepatic glucose production, insulin-stimulated glucose uptake, hyperinsulinemic-euglycemic clamp, mixed meal tolerance test, C-reactive protein, triglycerides, cholesterol
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.